PubHawk
Endoscopy June 2025 PMID 39848273

Outcomes of endoscopic submucosal dissection for high-risk colorectal colitis-associated neoplasia in inflammatory bowel disease.

Roberta Maselli, Roberto de Sire, Federico Barbaro, Paolo Cecinato, Gianluca Andrisani, Erik Rosa-Rizzotto, Sandro Sferrazza, Giancarla Fiori, Francesco Azzolini, Francesco Pugliese, Antonio Facciorusso, Marco Spadaccini, Antonio Capogreco, Davide Massimi, Ludovico Alfarone

Full text PDF Download social card

Mentions

16
Peak: 13 in Jun 2025
across 2 sources since Jan 2025

Extended reach

57,838
potential audience

Total likes

43

Video views

84

Mentions per month

Jan 2025 – Jun 2025

Where it's discussed

  • X / Twitter15 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions highlight the promising outcomes of ESD, with phrases like 'high effectiveness' and 'manageable complications,' indicating support and interest. The tone varies from supportive to analytical, with some users referencing the article directly, such as Roberta Maselli et al., and emphasizing its potential to impact treatment strategies in cases of high-risk colorectal neoplasia in IBD patients.

AgreementModerate agreement

Most posts express support for the study's positive findings on ESD outcomes in IBD patients.

InterestHigh interest

Discussions show strong interest, especially with mentions of the procedure's effectiveness and safety.

EngagementModerate engagement

Users engage by sharing additional insights, referencing the study, and linking to further resources.

ImpactModerate impact

Posts suggest the research could influence clinical practice, with some emphasizing its importance for treatment options.

Abstract in brief

  • This study looked at how effective endoscopic submucosal dissection (ESD) is for treating high-risk colorectal neoplasia in patients with inflammatory bowel disease (IBD), finding high rates of successful removal and manageable adverse events.
  • Most patients achieved complete (en bloc and R0) resections, with low recurrence rates (about 3 out of 10 patients experiencing local recurrence or new lesions) over an average follow-up of around 2 years.
  • The procedure was generally safe, with complications being manageable and only a small percentage needing additional surgery, suggesting ESD is a promising option for managing high-risk colorectal neoplasia in IBD patients.
Read the full abstract

Top posts

Most liked on X and Bluesky
Antonio Facciorusso
@AntonioFaccior6 · X

https://t.co/A3K6FTtR4D Our multicenter study published in @ESGE_news journal Endoscopy demonstrates the high effectiveness of ESD and hESD in IBD patients @robertamaselli1 @alerepici

Jan 24, 2025 · 16 likes · 2 shares · 752 followers View post →
Endoscopy Journal
@endoscopyjrnl · X

Outcomes of ESD for high-risk colorectal colitis-associated neoplasia in IBD Find the article at: https://t.co/72drtnDa1O Roberta Maselli et al. https://t.co/gFOm0iKrZs

Jun 24, 2025 · 10 likes · 7 shares · 11,554 followers View post →
Nayantara Coelho
@NayantaraCoelho · X

@MondayNightIBD @DCharabaty @abbvie @JanssenUS @TakedaPharma @nloganmd @fudmanMD @DrJordanAxelrad @DhereMdEmory @SchwartzbergMD @HolubarStefan @EdwardLoftus2 @ibdgijami @PMyrelid @AdamFayeMD https://t.co/Wm778zT1cK

Jun 9, 2025 · 9 likes · 4 shares · 1,150 followers View post →
Endoscopy Journal
@endoscopyjrnl · X

#AuthorCommentary: Roberta Maselli & Roberto de Sire on "Outcomes of endoscopic submucosal dissection for high-risk colorectal colitis-associated neoplasia in inflammatory bowel disease" Watch: https://t.co/lo1ruw3Dh7 Read: https://t.co/72drtnDa1O Roberta Maselli et al.

Jun 25, 2025 · 7 likes · 1 share · 11,554 followers View post →
Aline Charabaty, MD, FACG, AGAF
@DCharabaty · X

RT @NayantaraCoelho: @MondayNightIBD @DCharabaty @abbvie @JanssenUS @TakedaPharma @nloganmd @fudmanMD @DrJordanAxelrad @DhereMdEmory @Schwa…

Jun 10, 2025 · 4 shares · 19,942 followers View post →
#MondayNightIBD
@MondayNightIBD · X

RT @NayantaraCoelho: @MondayNightIBD @DCharabaty @abbvie @JanssenUS @TakedaPharma @nloganmd @fudmanMD @DrJordanAxelrad @DhereMdEmory @Schwa…

Jun 10, 2025 · 4 shares · 9,795 followers View post →

All mentions

calina
@calinox · X

RT @endoscopyjrnl: Outcomes of ESD for high-risk colorectal colitis-associated neoplasia in IBD Find the article at: https://t.co/72drtnDa…

Jun 29, 2025 · 7 shares · 262 followers View post →
Mohamed Shiha
@Mo_Shiha · X

RT @endoscopyjrnl: Outcomes of ESD for high-risk colorectal colitis-associated neoplasia in IBD Find the article at: https://t.co/72drtnDa…

Jun 28, 2025 · 7 shares · 828 followers View post →
Roberto de Sire
@RobideSire94 · X

RT @endoscopyjrnl: #AuthorCommentary: Roberta Maselli & Roberto de Sire on "Outcomes of endoscopic submucosal dissection for high-risk colo…

Jun 25, 2025 · 1 share · 29 followers View post →
Endoscopy Journal
@endoscopyjrnl · X

#AuthorCommentary: Roberta Maselli & Roberto de Sire on "Outcomes of endoscopic submucosal dissection for high-risk colorectal colitis-associated neoplasia in inflammatory bowel disease" Watch: https://t.co/lo1ruw3Dh7 Read: https://t.co/72drtnDa1O Roberta Maselli et al.

Jun 25, 2025 · 7 likes · 1 share · 11,554 followers View post →
Ary Rodríguez
@Ary_Rodriguez_ · X

RT @endoscopyjrnl: Outcomes of ESD for high-risk colorectal colitis-associated neoplasia in IBD Find the article at: https://t.co/72drtnDa…

Jun 24, 2025 · 7 shares · 444 followers View post →
Rui Mendo
@mendorui · X

RT @endoscopyjrnl: Outcomes of ESD for high-risk colorectal colitis-associated neoplasia in IBD Find the article at: https://t.co/72drtnDa…

Jun 24, 2025 · 7 shares · 138 followers View post →
Roberto de Sire
@RobideSire94 · X

RT @endoscopyjrnl: Outcomes of ESD for high-risk colorectal colitis-associated neoplasia in IBD Find the article at: https://t.co/72drtnDa…

Jun 24, 2025 · 7 shares · 29 followers View post →
Endoscopy Journal
@endoscopyjrnl · X

Outcomes of ESD for high-risk colorectal colitis-associated neoplasia in IBD Find the article at: https://t.co/72drtnDa1O Roberta Maselli et al. https://t.co/gFOm0iKrZs

Jun 24, 2025 · 10 likes · 7 shares · 11,554 followers View post →
Rakahn Haddadin
@RakahnHaddadin · X

RT @NayantaraCoelho: @MondayNightIBD @DCharabaty @abbvie @JanssenUS @TakedaPharma @nloganmd @fudmanMD @DrJordanAxelrad @DhereMdEmory @Schwa…

Jun 17, 2025 · 4 shares · 121 followers View post →
Mehak Bassi, MD, DipABOM
@BassiMehak · X

RT @NayantaraCoelho: @MondayNightIBD @DCharabaty @abbvie @JanssenUS @TakedaPharma @nloganmd @fudmanMD @DrJordanAxelrad @DhereMdEmory @Schwa…

Jun 12, 2025 · 4 shares · 991 followers View post →
Aline Charabaty, MD, FACG, AGAF
@DCharabaty · X

RT @NayantaraCoelho: @MondayNightIBD @DCharabaty @abbvie @JanssenUS @TakedaPharma @nloganmd @fudmanMD @DrJordanAxelrad @DhereMdEmory @Schwa…

Jun 10, 2025 · 4 shares · 19,942 followers View post →
#MondayNightIBD
@MondayNightIBD · X

RT @NayantaraCoelho: @MondayNightIBD @DCharabaty @abbvie @JanssenUS @TakedaPharma @nloganmd @fudmanMD @DrJordanAxelrad @DhereMdEmory @Schwa…

Jun 10, 2025 · 4 shares · 9,795 followers View post →
Nayantara Coelho
@NayantaraCoelho · X

@MondayNightIBD @DCharabaty @abbvie @JanssenUS @TakedaPharma @nloganmd @fudmanMD @DrJordanAxelrad @DhereMdEmory @SchwartzbergMD @HolubarStefan @EdwardLoftus2 @ibdgijami @PMyrelid @AdamFayeMD https://t.co/Wm778zT1cK

Jun 9, 2025 · 9 likes · 4 shares · 1,150 followers View post →
Roberto de Sire
@RobideSire94 · X

RT @AntonioFaccior6: https://t.co/A3K6FTtR4D Our multicenter study published in @ESGE_news journal Endoscopy demonstrates the high effect…

Jan 24, 2025 · 2 shares · 29 followers View post →
Antonio Facciorusso
@AntonioFaccior6 · X

https://t.co/A3K6FTtR4D Our multicenter study published in @ESGE_news journal Endoscopy demonstrates the high effectiveness of ESD and hESD in IBD patients @robertamaselli1 @alerepici

Jan 24, 2025 · 16 likes · 2 shares · 752 followers View post →